https://www.selleckchem.com/products/cy-09.html
001), but aniseikonia did not change (P = 0.73). In patients with BRVO who had micropsia (≤ -2.0%) at baseline, mean aniseikonia significantly improved from -4.8 ± 3.3% to -0.9 ± 1.4% (P 0.05). Aniseikonia after treatment significantly correlated with BCVA (P 0.05) and the presence of SRD at baseline (P 0.05). Majority of eyes with aniseikonia in BRVO had micropsia. The BCVA as well as the micropsia improved following treatment with IVR for BRVO. BCVA and the presence of SRD were predictors of post-treatment aniseikonia. Ma
Aimer
Commentaire
Partagez
